Active Ingredients
AGRAPHIS 30C
Agraphis Nutans
FDA Label NDC 68428-870
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Washington Homeopathic Products for the product Agraphis Nutans (NDC 68428-870). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, uses, keep out of reach of children, indications, stop use and ask doctor, directions, inactive ingredients, principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Uses
To relieve the symptoms of fainting.
Keep Out Of Reach Of Children
Keep this and all medicines out of reach of children.
Indications
Indications:
AGRAPHIS Enlarged tonsils
Stop Use And Ask Doctor
If symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.
Directions
Adults: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides. Children: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides.
Inactive Ingredients
Sucrose/Lactose
Principal Display Panel
The OTC potency range of AGRAPHIS is 2x–30x, 1c–30c, 200c, 1m, 10m, 50m, and CM.
Availability is subject to change.
Agraphis Label Example (Agraphis30c1oz Label)
All WHP single remedies are made to order; thus, the labels are printed on the same label stock as the orders are filled.
‘Bottle Size’ and ‘Potency’ vary on the label depending on customer choice.
Standard bottle sizes for pellet-form remedies are 2 dram, 4 dram, 1 ounce, 2 ounce, and 4 ounce.
* Please review the disclaimer below.
